Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Malignant lymphoma: pathophysiology and current therapy.

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2017

Izutsu Koji

Abstract excerpt

Recent advances in the understanding of molecular pathogenesis of lymphoma have enabled us to clearly define disease entity by means of a disease-specific gene mutation and to select candidates for novel targeted therapy. In this review three different clinically relevant topics related to the molecular pathogenesis of lymphoma were covered. In the 2016 revision of the World Health Organization classification of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to BRAF gene
Share to MYD88 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma

Share to Molecular Targeted Therapy

Share to Mutation

Source

Identifiers

PMID: 28592763
DOI: 10.11406/rinketsu.58.480

Genes

BRAF
MYD88

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Malignant lymphoma: pathophysiology and current therapy.PMID 28592763Read ↗

New Insights into Lymphoma PathogenesisSemantic proximity Read ↗

Unraveling MCL biology to understand resistance and identify vulnerabilitiesSemantic proximity Read ↗

New targeted therapies for malignant lymphoma based on molecular heterogeneity.Semantic proximity Read ↗

Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.Semantic proximity Read ↗

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma CellsSemantic proximity Read ↗

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementSemantic proximity Read ↗

Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic eraSemantic proximity Read ↗

Mantle cell lymphoma: evolving management strategies.Semantic proximity Read ↗

Mantle cell lymphoma pathology update in the 2016 WHO classificationSemantic proximity Read ↗

Precision therapy for lymphoma--current state and future directions.Semantic proximity Read ↗

Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Case-Illustrated Narrative ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.